Simplifying clinical lab procurement at the UK’s only lab-dedicated showcase
Michael Brady calls for nationwide PrEP rollout
Britain’s first LGBT+ health adviser has backed calls to roll out HIV prevention pill PrEP nationwide, arguing it would save the NHS a significant amount of money.
Dr. Michael Brady, who was appointed as the first-ever National Adviser for LGBT+ Health, said there was “no doubt about the cost effectiveness of PrEP (Pre-Exposure Prophylaxis).”
Speaking to Reuters, Dr. Brady, who is currently Medical Director of the Terrence Higgins Trust (THT), said that for him “the argument has always been one of cost effectiveness not cost.”
“You actually put money back into the NHS pot very quickly by not having to spend £300,000 on lifetime treatment costs for HIV,” said Dr. Brady, who will take up his position on April 1.
NHS England is currently halfway through its PrEP Impact Trial, which began with 10,000 participants but the NHS last month agreed to increase to 26,000 after gay and bisexual men were turned away from trial sites that reached capacity.